Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
567.75
+7.99 (1.43%)
Jul 11, 2025, 4:00 PM - Market closed

Regeneron Pharmaceuticals (REGN) Revenue by Segment

History

Date Collaboration Net Product Other
Mar 31, 2025 6.32B 7.28B 480.00M
Dec 31, 2024 6.06B 7.63B 515.00M
Sep 30, 2024 5.82B 7.48B 548.10M
Jun 30, 2024 5.60B 7.32B 572.20M
Mar 31, 2024 5.39B 7.17B 537.00M
Dec 31, 2023 5.50B 7.08B 536.10M
Sep 30, 2023 5.72B 6.93B 451.30M
Jun 30, 2023 5.33B 6.94B 397.20M
Mar 31, 2023 5.06B 6.92B 387.10M
Dec 31, 2022 4.91B 6.89B 365.10M
Sep 30, 2022 4.22B 9.17B 323.60M
Jun 30, 2022 4.24B 9.65B 338.40M
Mar 31, 2022 4.15B 12.03B 325.20M
Dec 31, 2021 3.67B 12.12B 281.20M
Sep 30, 2021 3.46B 9.76B 318.40M
Jun 30, 2021 3.04B 8.97B 378.00M
Mar 31, 2021 2.60B 6.06B 543.80M
Dec 31, 2020 2.37B 5.57B 557.00M
Sep 30, 2020 2.18B 5.23B 529.10M
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.